Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 59 out of 100. Digital health tools

Topic: Risk, prevention and care in population studies

BackgroundAccurate and accessible risk assessment tools are essential for effective dementia management. The Cardiovascular Risk Factors, Aging, and Incidence of Dementia (CAIDE) model is the widely used tool to assess mid-life dementia risk.ObjectiveTo determine whether adding resting heart rate (RHR), a simple, readily measurable, non-invasive vital sign, improves dementia risk prediction within the CAIDE model using machine learning methods.MethodsData from 27,768 participants of comprehensive cohort in the Canadian Longitudinal Study on Aging were analyzed to predict 3-year dementia risk. Predictive models were developed using random forest and support vector machine algorithms. Performance was assessed using key metrics, including area under the receiver operating characteristic curve (AUC), sensitivity, specificity, Matthew's correlation coefficient (MCC), and Brier score. Internal cross-validation was used to ensure model robustness.ResultsAmong the 18,013 participants with complete data for analysis, 516 (2.86%) exhibited dementia. Incorporating RHR into the CAIDE model led to a significant improvement in predictive accuracy. Random forest models with RHR achieved an AUC of 0.67 and an MCC of 0.32 in training data, compared to 0.65 and 0.29 in the test data. Similarly, support vector machines demonstrated a 2-3% increase in both AUC and MCC with the inclusion of RHR.ConclusionsIncorporating RHR modestly but significantly improves the predictive performance of the CAIDE model using machine learning methods. This approach may support earlier identification of at-risk individuals using non-invasive, routinely available data, representing a step toward scalable and practical dementia risk screening in clinical and community settings.

Key findings

Why it matters

Adding resting heart rate to an existing dementia risk model modestly but significantly improved how well the model predicted 3-year dementia risk in a large Canadian cohort. This is a risk prediction tool, not a treatment, cure, or prevention of Alzheimer's disease.

Study details

How this study scored 59/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 4 of 4; Effect reported 2 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 2 of 7; Citations per year 1 of 5; Impact for its field and year 3 of 6; Cited by studies here 1 of 6; Still being cited 1 of 4; Senior author's track record left out, no data; Institution's track record 1 of 3; Multi-centre collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. 57 of the 96 points it could be judged on, which is 59 of 100. Total 59 of 100.57 of the 96 points we could judge = 59 of 100

Published in a peer-reviewed journal, and it is a longitudinal study following the same people over time. Scored zero for randomised / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 57 of the 96 points we could judge it on, which is 59 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Journal of Alzheimer s Disease)
Journal's citation record 2 / 4 Journal of Alzheimer s Disease: journal h-index 218 (OpenAlex, 2026-10-29)
Study design 7 / 12 A longitudinal study following the same people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 4 / 4 27,768 participants
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 2 / 7 Cited 8 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 2.7 citations a year over 3 year(s) since 2025
Impact for its field and year 3 / 6 Cited 5.1× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 1 / 6 Cited by 1 other studies in this library
Still being cited 1 / 4 Cited 8 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record 1 / 3 Queen's University: institution h-index 794 (OpenAlex)
Multi-centre collaboration 2 / 3 OpenAlex lists 4 institution(s) in 3 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41160465)
Free to read 2 / 2 Free to read
Points 57 / 96 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 57 of the 96 points we could judge it on is 59 out of 100.
Total 59 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Alaka, S. A., Ngan, S. C., MacPherson, R. E. K., Pickett, W., Chen, C., & Sze, S. K. (2025). Enhancing dementia risk prediction with heart rate and machine learning in the Canadian Longitudinal Study on Aging. Journal of Alzheimer s Disease. https://doi.org/10.1177/13872877251390562

Vancouver

Alaka SA, Ngan SC, MacPherson REK, Pickett W, Chen C, Sze SK. Enhancing dementia risk prediction with heart rate and machine learning in the Canadian Longitudinal Study on Aging. Journal of Alzheimer s Disease. 2025. doi:10.1177/13872877251390562. PMID: 41160465.

BibTeX

@article{alaka2025-41160465,
  author  = {Alaka, Shakiru A and Ngan, SoFong Cam and MacPherson, Rebecca E. K. and Pickett, William and Chen, Christopher and Sze, Siu Kwan},
  title   = {{Enhancing dementia risk prediction with heart rate and machine learning in the Canadian Longitudinal Study on Aging}},
  journal = {Journal of Alzheimer s Disease},
  year    = {2025},
  doi     = {10.1177/13872877251390562},
  pmid    = {41160465},
  url     = {https://doi.org/10.1177/13872877251390562}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Later studies that cite this one

1 study in the alzhub library lists this one in its references.

Related studies in Digital health tools

Similar studies

More on Digital health tools

See all studies in Digital health tools →